BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 8649982)

  • 1. Trans-splicing and alternative-tandem-cis-splicing: two ways by which mammalian cells generate a truncated SV40 T-antigen.
    Eul J; Graessmann M; Graessmann A
    Nucleic Acids Res; 1996 May; 24(9):1653-61. PubMed ID: 8649982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental evidence for RNA trans-splicing in mammalian cells.
    Eul J; Graessmann M; Graessmann A
    EMBO J; 1995 Jul; 14(13):3226-35. PubMed ID: 7542587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synthesized SV40 cRNA is trans-spliced after microinjection into the nuclei of mammalian cells.
    Eul J; Graessmann M; Graessmann A
    FEBS Lett; 1996 Sep; 394(2):227-32. PubMed ID: 8843169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SV40 T1-mRNA trans-splicing and translation requires that the in vitro synthesized cRNA is capped before microinjection.
    Graessmann M; Eul J; Berg B; Zimmermann C; Graessmann A
    FEBS Lett; 1996 Sep; 394(2):233-6. PubMed ID: 8843170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homologous SV40 RNA trans-splicing: a new mechanism for diversification of viral sequences and phenotypes.
    Eul J; Patzel V
    RNA Biol; 2013 Nov; 10(11):1689-99. PubMed ID: 24178438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous HIV-nef mRNA trans-splicing: a new principle how mammalian cells generate hybrid mRNA and protein molecules.
    Caudevilla C; Da Silva-Azevedo L; Berg B; Guhl E; Graessmann M; Graessmann A
    FEBS Lett; 2001 Nov; 507(3):269-79. PubMed ID: 11696354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene.
    Nishiyama T; Hatano H; Kurosaka M; Bolander ME; Sarkar G
    J Bone Miner Res; 2003 Sep; 18(9):1716-22. PubMed ID: 12968682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyoma virus small tumor antigen pre-mRNA splicing requires cooperation between two 3' splice sites.
    Ge H; Noble J; Colgan J; Manley JL
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3338-42. PubMed ID: 2159146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor site competition is involved in the regulation of alternative splicing of the rat beta-tropomyosin pre-mRNA.
    Chen CD; Helfman DM
    RNA; 1999 Feb; 5(2):290-301. PubMed ID: 10024180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of splice sites in the early region of bovine polyomavirus: evidence for a unique pattern of large T mRNA splicing.
    Schuurman R; Jacobs M; van Strien A; van der Noordaa J; Sol C
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2879-86. PubMed ID: 1279101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple cis-acting sequence elements are required for efficient splicing of simian virus 40 small-t antigen pre-mRNA.
    Fu XY; Colgan JD; Manley JL
    Mol Cell Biol; 1988 Sep; 8(9):3582-90. PubMed ID: 2851720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cis requirements for alternative splicing of the cardiac troponin T pre-mRNA.
    Cooper TA; Cardone MH; Ordahl CP
    Nucleic Acids Res; 1988 Sep; 16(17):8443-65. PubMed ID: 3419923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T antigen.
    Shew JY; Chen PL; Bookstein R; Lee EY; Lee WH
    Cell Growth Differ; 1990 Jan; 1(1):17-25. PubMed ID: 1964074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative splicing of SV40 early pre-mRNA in vitro.
    van Santen VL; Spritz RA
    Nucleic Acids Res; 1986 Dec; 14(24):9911-26. PubMed ID: 3027668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splice site choice in a complex transcription unit containing multiple inefficient polyadenylation signals.
    Luo Y; Carmichael GG
    Mol Cell Biol; 1991 Oct; 11(10):5291-300. PubMed ID: 1656228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA.
    Zerrahn J; Knippschild U; Winkler T; Deppert W
    EMBO J; 1993 Dec; 12(12):4739-46. PubMed ID: 8223482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splice site skipping in polyomavirus late pre-mRNA processing.
    Luo Y; Carmichael GG
    J Virol; 1991 Dec; 65(12):6637-44. PubMed ID: 1719232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
    Hennig EE; Conney AH; Wei SJ
    Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions.
    Thanaraj TA; Clark F
    Nucleic Acids Res; 2001 Jun; 29(12):2581-93. PubMed ID: 11410667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing in the neural cell adhesion molecule pre-mRNA: regulation of exon 18 skipping depends on the 5'-splice site.
    Tacke R; Goridis C
    Genes Dev; 1991 Aug; 5(8):1416-29. PubMed ID: 1869048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.